Streetbeat News

Earnings

CRIS

Curis, Inc. will release its Q3 2024 financial and operating results on November 14, 2024. The company is focused on developing emavusertib, an IRAK4 inhibitor.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

DARE

Daré Bioscience will host a conference call and webcast on November 14, 2024, to discuss its Q3 2024 financial results and provide a company update. The results will be released after market close on the same day.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

VRME

VerifyMe, Inc. (NASDAQ: VRME) will release its Q3 2024 financial results on November 12, 2024. The company provides logistics, supply chain traceability, authentication, and brand enhancement services.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

LPCN

Lipocine Inc. (NASDAQ: LPCN) reported its financial results for Q3 2024, highlighting the development of its neuroactive steroid LPCN 1154 for postpartum depression.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

NRBO

NeuroBo Pharmaceuticals reported positive top-line data from its Phase 1 trial of DA-1726 for obesity, showing favorable safety and pharmacokinetics. The company has $21.7 million in cash, expected to fund operations into Q3 2025. Upcoming results include Phase 2a trial of DA-1241 for MASH in December 2024 and MAD Part 2 of DA-1726 in Q1 2025. A joint research agreement was entered with Dong-A ST and ImmunoForge for a long-acting formulation of DA-1726.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

UP

Wheels Up Experience Inc. (NYSE:UP) reported its Q3 2024 results, showing improved financial performance due to strategic initiatives. Revenue stabilized at $194 million, with a record adjusted contribution margin of 14.8%. The net loss improved significantly, and a new credit facility backed by Delta Air Lines is expected to strengthen the balance sheet.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

KLG

WK Kellogg Co announced its third quarter financial results and raised its 2024 adjusted EBITDA guidance, indicating positive financial performance and outlook.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

DE

Deere & Company (NYSE: DE) is set to announce its fourth quarter 2024 financial results on November 21, 2024. The earnings call will begin at 9:00 a.m.

Portfolio Pulse from

November 07, 2024 | 1:15 pm

BUR

Burford Capital Limited announced its unaudited financial results for the third quarter of 2024, highlighting its performance in the global finance and asset management sector focused on law.

Portfolio Pulse from

November 07, 2024 | 1:00 pm

PBA

Pembina Pipeline's Q3 earnings missed estimates, with a year-over-year decline in sales. The company projects adjusted EBITDA between C$4.23-C$4.33 billion for 2024 and aims to maintain a debt-to-adjusted EBITDA ratio of 3.4-3.6 times.

Portfolio Pulse from

November 07, 2024 | 1:00 pm